Today on High On Healthy our host is joined by Sid Taubenfeld CEO of Tikun’s Pharma (TO Pharma) division. Tikun Olam (“repair the world” in Hebrew) is privately held and has been operating under license from the Israel Ministry of Health since its establishment in 2006, by the Cohen Family. The company is a vertically integrated company from plant cultivation to patient administration. Tikun Olam Grows medical cannabis cultivated in state-of-the-art standards. Tikun Olam has developed multiple proprietary award winning strains, including the first-ever, high-CBD, “high-less” strain Avidekel™, its popular high-THC strains Alaska™ and Erez™, and “one-to-one” CBD/THC strain Midnight™. Tikun Olam Research holds unprecedented patient clinical data collection. The company products are used in ongoing clinical trials in Israel's regulated medical cannabis market. Tikun Olam Care the world’s first professional cannabis nursing clinic; one of its most recognized achievements. Tikun Olam provides safe and personalized treatment for all ages ranging from pediatric to geriatric patients, treating over 20,000 patients for a variety of medical conditions.
Cannabis Business Interviews: Is Europe the Future of Cannabis? Steven Murphy Weighs In
This engaging discussion with Richard Zwicky and Steven Murphy, CEO of Prohibition Partners, explores the dynamic world of the global cannabis industry, offering valuable insights into current trends, regulatory challenges, and emerging opportunities. Steven and Read more…